This effect was moderately significant (p = .02) and the interaction was retained.
Excerpts
The difference between the three groups for ER positivity was highly significant (Chi-square=8.53, P<0.02).
In the case of BMI, in contrast to the observational results, the instrumental analyses showed a positive ES in BarcUVa-Seq and GTEx (2.47, p -value = 0.003; 2.98, p -value = 0.006) but a negative trend in CEDAR (−1.38, p -value = 0.02) ( Table 4 ).
However, patients in most age groups showed higher rates of seroprevalence; whereas the differences in individual age groups did not reach statistical significance, the difference among these prevalences in all age groups taken together was statistically significant (p = 0.02).
borderline significanceP=0.020
The patients with an early form of SSc had markedly lower concentrations of BNP than subjects with a late form, although with borderline significance (reached P=0.020 vs.
In head and neck squamous cell carcinoma, ROH was not significantly associated with cancer risk for females but was nominally significant for males ( p = 0.02 ) .
13 The latest release of UAM Corpus Tool (version 6.2j, February 2023) does not allow complex within-group comparisons, so we used an earlier release (version 3.3x, August 2021) to do the analysis, though note that version 3.3x reports p value ranges (non significant p > 0.05, significant p < 0.05, highly significant p < 0.02) and does not report effect size.
At day 45, the difference among the groups was nominally significant ( P = .02). 38 Post hoc analyses indicate that patients who received zuranolone experienced positive effects on insomnia symptoms and their overall functional health and well-being, as reported by the patients themselves. 40 , 41 Patients who participated in the ROBIN study were randomly assigned to receive either zuranolone 30 mg or placebo, both taken once daily with an evening meal for a duration of 14 days.
Although the scores did not show significant differences between groups 2 and 3, there was a marginally significant differences (p=0.020) between the 2 groups, with a clear difference between groups 1 and 3 (p=0.002).
In contrast, the genetic correlation between self-harm phenotypes and chronic pain were relatively weak and either marginally significant or nonsignificant (self-harm ideation: r g [95% CI] = 0.14 [0.05 to 0.22], p = .02; self-harm behavior: r g [95% CI] = 0.13 [0.01 to 0.26], p = .47).
While the difference did not reach statistical significance, the improvement in EFS was attributed to a significant reduction in systemic relapses (22% vs. 39%, p = 0.02), particularly lung metastases (7.3% vs. 20.9%) [ 5 ].
The content of pyruvic acid significantly decreased ( p = 0.045), the content of DL-3-phenyllactic acid also showed a decreasing trend ( p = 0.020), L-Cystine increased ( p = 0.009), and glutamine significantly increased ( p < 0.001).
Single-Parent Poverty & Maternal Substance Use: M difference = 5.12, p = .01, FDR p = .02), and higher estimates than males in Maternal Substance Use at age 15, but did not reach statistical significance after FDR correction ( M difference = 3.19, p = .02, FDR p = .10).
Moreover, rs9313619 remained genome-wide significant when conditioning on rs29784 (conditional P = 3.50 × 10 −8 ), while if conditioning on rs9313619, the previously reported top SNP rs29784 remained only nominally significant ( P = 0.02).
For binary classification of 40 external slides scanned on the GT450, the performance difference between the model and pathologists was borderline significant (P = 0.02), suggesting high model performance on this dataset.
Serum Ang-1 levels did not change significantly in cholecalciferol group (mean change: 1.36 ng/ml; 95% CI: -2.39 to 5.11 ; p = 0.280; Table 3 ) while in placebo group showed an increasing trend (mean change: 5.63 ng/ml; 95%CI: 0.51 to 10.75; p = 0.020).
Analyses stratified by ethnicity showed similar ORs, but it did not reach statistical significance for the Pacific women ((OR: 0.90 [95% CI: 0.82, 0.98] p = 0.020) in European vs.
The opposite pattern was observed for MLR model based on female specific metabolites, which resulted in a good predictive power (AUC = 0.87, p < 0.0001) for RCC diagnosis among females ( Figure 5 C), while in males this model was borderline significant with p = 0.02 and AUC of 0.68 ( Figure 5 D).
showed a trendp = 0.020
While task-irrelevant thermal input tended to prolong RTs in the visual task under low load ( p = 0.033, q = 0.099), task-irrelevant visual input showed a trend-level improvement in thermal-task accuracy under high load (3-back; p = 0.020, q = 0.060), consistent with a potential cross-modal effect.
They found that the fornix body volume and DA were highly significant predictors of cognitive decline from normal cognition [ r = =0.47 (0.24–0.89), p = 0.02, and r = =1.25 (1.02–1.46), p = 0.005, respectively].
In a joint regression model including a snp:drug type interaction term, we determined the difference to be weakly significant ( P = 0.02).
Among the patients exhibiting psychiatric symptoms, 68.8% (22/32) also presented with hyponatremia, indicating a highly significant correlation between the two conditions ( p = 0.02).
To this end, we performed qRT-PCR on CD34 + cells isolated from adult bone marrow donors (n=11) and found a highly significant correlation between RINF mRNA and SMAD7 mRNA (Pearson, rho=0.684, P =0.02) ( Figure 6A ).
showed a trendp = 0.02
Similar results were obtained when analyzing the NTs in the EC of Cohort II; the co-localization between p-tau217/p-tau231 and p-tau231/p-tau205 was significantly lower, and p-tau217/p-tau205 showed a trend to lower co-localization in AD high compared to PART ( p = 0.02, p = 0.04, and p = 0.06, respectively).
borderline significanceP = .02
In vaccinated-only participants, PLWH seemed to have a stronger vaccine-elicited neutralization of Delta with borderline significance ( Figure 2C ) (GMT=6 [2.8-15.4] for HIV-negative, 73 [7.9-677] for PLWH; P = .02).